Choice of medications when treating stable COPD.
作者信息
Vestbo Jørgen
出版信息
Clin Respir J. 2010 Oct;4(4):195-6. doi: 10.1111/j.1752-699X.2010.00209.x.
Abstract
摘要
相似文献
1
Choice of medications when treating stable COPD.
Clin Respir J. 2010 Oct;4(4):195-6. doi: 10.1111/j.1752-699X.2010.00209.x.
2
[Drug therapy of airway obstruction. "Completely different for asthma and COPD"].
MMW Fortschr Med. 2008 May 15;150(20):14, 16.
3
Emerging trends in the therapy of COPD: bronchodilators as mono- and combination therapies.
Drug Discov Today. 2007 Jun;12(11-12):472-8. doi: 10.1016/j.drudis.2007.04.003. Epub 2007 Apr 26.
4
Tiotropium in chronic obstructive pulmonary disease.
N Engl J Med. 2009 Jan 8;360(2):185; author reply 187. doi: 10.1056/NEJMc082265.
5
[How risky are beta-2 mimetics?].
MMW Fortschr Med. 2006 Aug 17;148(33-34):10.
6
Chronic obstructive pulmonary disease.
Clin Evid. 2006 Jun(15):2077-100.
7
Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes.
Clin Ther. 2007 Oct;29(10):2121-33. doi: 10.1016/j.clinthera.2007.10.006.
8
Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
Ann Pharmacother. 2010 Apr;44(4):613-22. doi: 10.1345/aph.1M243. Epub 2010 Mar 16.
9
Clinical practice. Outpatient management of severe COPD.
N Engl J Med. 2010 Apr 15;362(15):1407-16. doi: 10.1056/NEJMcp0912556.
10
[Inhaled combination therapy with corticosteroids and long-acting beta-2 agonists in chronic obstructive pulmonary disease].
Zhonghua Jie He He Hu Xi Za Zhi. 2008 Dec;31(12):928-30.
Zotero 插件